[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-236317-105":53,"doc-detail-236317-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","gold-2025-report-global-strategy-for-the-diagnosis-management-and-prevention-of-chronic-obstructive-pulmonary-disease-2025-report","GOLD 2025 Report - Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2025 Report","","Global Initiative for Chronic Obstructive Lung Disease (GOLD) provides the 2025 report outlining a global strategy for diagnosing, managing, and preventing chronic obstructive pulmonary disease. The materials emphasize that clinical relevance and patient applicability must be assessed and determined by qualified health care professionals. The report notes that only the English version has been reviewed and approved, and stresses the need to confirm the most current content version. GOLD expressly disclaims liability related to misuse or misapplication of the information provided.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/gold-2025-report-global-strategy-for-the-diagnosis-management-and-prevention-of-chronic-obstructive-pulmonary-disease-2025-report/236317/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/gold-2025-report-global-strategy-for-the-diagnosis-management-and-prevention-of-chronic-obstructive-pulmonary-disease-2025-report/236317.png","ImageObject",442,249,{"name":88,"@type":89},"Anda","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-22","2026-09-11",true,{"@type":98,"interactionType":99,"userInteractionCount":20},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the purpose of the GOLD 2025 report?","Question",{"text":108,"@type":109},"The report provides information to help users understand GOLD conclusions regarding the diagnosis, management, and prevention of COPD, as of the specific information approval date.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"How should the report’s recommendations be used in patient care?",{"text":113,"@type":109},"Relevance to a particular patient or case must be carefully assessed and evaluated by a qualified health care professional treating that patient.",{"name":115,"@type":106,"acceptedAnswer":116},"Which language version is approved, and what must users ensure?",{"text":117,"@type":109},"Only the English language version has been reviewed and approved by GOLD; users must ensure they are using the most current version because updates may occur after initial release.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},236317,1791522300,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":20,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":141},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Global Initiative for Chronic Obstructive Lung Disease  \n2025 REPORT  \nGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease  \nGLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG  \nDISEASE  \nGLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY  \nDISEASE  \n(2025 REPORT)  \n© 2024, 2025 Global Initiative for Chronic Obstructive Lung Disease, Inc.  \nImportant Purpose & Liability Disclaimer  \nThe information provided by Global Initiative for Chronic Obstructive Lung Disease (“GOLD”) for inclusion in its materials, website, and applications (including but not limited to web based or digital applications) is provided for the convenience of users to help them understand the conclusions of GOLD as of the date of the specific information’s approval by GOLD. That information’s relevance to, and/or application to, a particular patient or case must be carefully assessed, evaluated, and determined by a qualified health care professional treating that patient or case. Users need to be aware of the fact that only the English language version of GOLD’s information has been reviewed and approved by GOLD, and that users must ensure that they have the most current version of GOLD’s information since GOLD’s information may have been updated or changed after its original release. Especially in light of the above, GOLD expressly disclaims any liability arising out of any use or misuse of the information it provides.  \nGOLD BOARD OF DIRECTORS  \n(2024)  \nGOLD SCIENCE COMMITTEE*  \n(2024)  \nAlvar Agusti, MD, Chair Respiratory Institute Hospital Clinic, IDIBAPSUniv. Barcelona and Ciberes Barcelona, Spain  \nBartolome R. Celli, MD Harvard Medical School Boston, Massachusetts, USA  \nGerard Criner, MD  \nTemple University School of Medicine Philadelphia, Pennsylvania, USA  \nDavid Halpin, MD  \nUniversity of Exeter Medical School College of Medicine and Health University of Exeter, Exeter Devon, UK  \nMaria Montes de Oca, MD Hospital Universitario de Caracas Universidad Central de Venezuela Centro Médico de Caracas Caracas, Venezuela  \nObianuju B. Ozoh, MD University of Lagos Lagos, Nigeria  \nSundeep Salvi, MD  \nPulmocare Research and Education (PURE) Foundation  \nPune, India  \nClaus Vogelmeier, MD University of Marburg Marburg, Germany  \nJinping Zheng, MD  \nGuangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China  \nGOLD EXECUTIVE DIRECTOR  \nKatie Langefeld, BS Illinois, USA  \nClaus Vogelmeier, MD, Chair University of Marburg  \nMarburg, Germany  \nAlvar Agusti, MD  \nRespiratory Institute  \nHospital Clinic, IDIBAPSUniv. Barcelona and Ciberes Barcelona, Spain  \nAntonio Anzueto, MD  \nSouth Texas Veterans Health Care System,  \nUniversity of Texas, Health  \nSan Antonio, Texas, USA  \nJean Bourbeau, MD  \nMcGill University Health Centre  \nMcGill University  \nMontreal, Canada  \nGerard Criner, MD  \nTemple University School of Medicine Philadelphia, Pennsylvania, USA  \nDavid Halpin, MD  \nUniversity of Exeter Medical School College of Medicine and Health University of Exeter, Exeter Devon, UK  \nMeiLan K. Han, MD MS  \nUniversity of Michigan  \nAnn Arbor, MI, USA  \nFernando J. Martinez, MD MS University of Massachusetts Chan Medical School  \nWorcester, MA, USA  \nMaria Montes de Oca, MD Hospital Universitario de Caracas Universidad Central de Venezuela Centro Médico de Caracas  \nCaracas, Venezuela  \nObianuju B. Ozoh, MD  \nUniversity of Lagos  \nLagos, Nigeria  \nEDITORIAL ASSISTANCE  \nRuth Hadfield, PhD Macquarie University AIHI Sydney, Australia  \nADMIN ASSISTANCE  \nAshley Dear  \nAlberto Papi, MD University of Ferrara Ferrara, Italy  \nIan Pavord, DM FMedSci  \nRespiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine University of Oxford  \nOxford, UK  \nNicolas Roche, MD  \nPneumologie, Hôpital Cochin  \nAP-HP.Centre – Université Paris Cité UMR 1016  \nInstitut Cochin Paris, France  \n","cbCaipxslfEfBL18","https://ap.wps.com/l/cbCaipxslfEfBL18","pdf",16712294,215,"English","# Important Purpose & Liability Disclaimer\n## GOLD Governance and Committees\n## Global Strategy for the Diagnosis, Management, and Prevention of COPD (2025)\n## Acknowledgements","[{\"question\":\"What is the purpose of the GOLD 2025 report?\",\"answer\":\"The report provides information to help users understand GOLD conclusions regarding the diagnosis, management, and prevention of COPD, as of the specific information approval date.\"},{\"question\":\"How should the report’s recommendations be used in patient care?\",\"answer\":\"Relevance to a particular patient or case must be carefully assessed and evaluated by a qualified health care professional treating that patient.\"},{\"question\":\"Which language version is approved, and what must users ensure?\",\"answer\":\"Only the English language version has been reviewed and approved by GOLD; users must ensure they are using the most current version because updates may occur after initial release.\"}]","GOLD 2025 Report - Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2025 Report | PDF",1789104507,75]